State of Maine Legislature

Actions for LD 538

Bill Info

LD 538 (HP 357)

"An Act to Amend Maine's Prescription Drug Labeling Law by Allowing the Removal of the Name of a Prescriber of Mifepristone, Misoprostol and Their Generic Alternatives"

Sponsored by Representative Sally Cluchey

Date	Chamber	Action
2/11/2025	House	Committee on Health Coverage, Insurance and Financial Services suggested and ordered printed. The Bill was REFERRED to the Committee on HEALTH COVERAGE, INSURANCE AND FINANCIAL SERVICES. Sent for concurrence. ORDERED SENT FORTHWITH.
2/11/2025	Senate	The Bill was REFERRED to the Committee on HEALTH COVERAGE, INSURANCE AND FINANCIAL SERVICES in concurrence
3/21/2025	House	Carried over, in the same posture, to the next special or regular session of the 132nd Legislature, pursuant to Joint Order SP 519.
5/20/2025	House	Reports READ. On motion of Representative MATHIESON of Kittery, the Majority Ought to Pass as Amended Report was ACCEPTED. ROLL CALL NO. 148 (Yeas 75 - Nays 71 - Absent 4 - Excused 0 - Restricted - 1) The Bill was READ ONCE. Committee Amendment "A" (H-179) was READ and ADOPTED. Under suspension of the rules, the Bill was given its SECOND READING without REFERENCE to the Committee on Bills in the Second Reading. The Bill was PASSED TO BE ENGROSSED as Amended by Committee Amendment "A" (H-179). Sent for concurrence. ORDERED SENT FORTHWITH.
5/21/2025	Senate	Reports Read On motion by Senator BAILEY of York the Majority Ought to Pass as Amended Report ACCEPTED. PREVAILED Roll Call Ordered Roll Call Number 198 Yeas 19 - Nays 13 - Excused 3 - Absent 0 Bill READ ONCE Committee Amendment "A" (H-179) READ and ADOPTED Under suspension of the Rules, READ A SECOND TIME and PASSED TO BE ENGROSSED AS AMENDED by Committee Amendment "A" (H-179) in concurrence.